---
title: "EBOS Group Limited (EBO) Gets a Buy from Citi"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/298518583.md"
description: "Citi analyst Laura Sutcliffe maintained a Buy rating on EBOS Group Limited today and set a price target of A$22.50. Sutcliffe covers the Healthcare sector, focusing on stocks such as CSL, Telix Pharmaceuticals, and Ramsay Health Care. According to TipRanks, Sutcliffe has an average return of 1.3% and a 50.29% success rate on recommended stocks. EBOS Group Limited has an analyst consensus of Strong Buy, with a price target consensus of A$23.81."
datetime: "2026-09-10T00:35:22.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/298518583.md)
  - [en](https://longbridge.com/en/news/298518583.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/298518583.md)
generator: "portal-rs"
---

# EBOS Group Limited (EBO) Gets a Buy from Citi

Citi analyst Laura Sutcliffe maintained a Buy rating on EBOS Group Limited today and set a price target of A$22.50.

Sutcliffe covers the Healthcare sector, focusing on stocks such as CSL, Telix Pharmaceuticals, and Ramsay Health Care. According to TipRanks, Sutcliffe has an average return of 1.3% and a 50.29% success rate on recommended stocks. 

EBOS Group Limited has an analyst consensus of Strong Buy, with a price target consensus of A$23.81.

### Related Stocks

- [EBO.AU](https://longbridge.com/en/quote/EBO.AU.md)
- [C.US](https://longbridge.com/en/quote/C.US.md)
- [CSL.AU](https://longbridge.com/en/quote/CSL.AU.md)
- [CSLLY.US](https://longbridge.com/en/quote/CSLLY.US.md)
- [TLX.AU](https://longbridge.com/en/quote/TLX.AU.md)
- [TLX.US](https://longbridge.com/en/quote/TLX.US.md)
- [RHC.AU](https://longbridge.com/en/quote/RHC.AU.md)
- [C-R.US](https://longbridge.com/en/quote/C-R.US.md)

## Related News & Research

- [Morgans Sticks to Its Buy Rating for EBOS Group Limited (EBO)](https://longbridge.com/en/news/296414163.md)
- [Citi Remains a Buy on EBOS Group Limited (EBO)](https://longbridge.com/en/news/292690737.md)
- [Citi Reaffirms Their Buy Rating on Pro Medicus Limited (PMCUF)](https://longbridge.com/en/news/298518238.md)
- [Citi Keeps Their Hold Rating on Cochlear  (CHEOF)](https://longbridge.com/en/news/298516761.md)
- [Macquarie Keeps Their Hold Rating on Region Group (SCPAF)](https://longbridge.com/en/news/298185411.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**